Nephritis, cerebritis, and myositis after adalimumab therapy in a patient with rheumatoid arthritis: a case report
Narges E Omran,1 Abdulsalam A Noorwali2 1Department of Internal Medicine and Rheumatology, Al-Noor Specialist Hospital, Makkah, Saudi Arabia; 2Department of Internal Medicine and Rheumatology, Umm Al Qura University Hospital, Makkah, Saudi Arabia Abstract: Rheumatoid arthritis (RA) is a chronic infl...
Main Authors: | Omran NE, Noorwali AA |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2018-04-01
|
Series: | International Journal of General Medicine |
Subjects: | |
Online Access: | https://www.dovepress.com/nephritis-cerebritis-and-myositis-after-adalimumab-therapy-in-a-patien-peer-reviewed-article-IJGM |
Similar Items
-
Sexual dysfunction in a patient with rheumatoid arthritis treated with adalimumab
by: Levent Yazmalar, et al.
Published: (2015-06-01) -
Adalimumab Induced Systemic Lupus Erythematosus
by: Songül Çildağ, et al.
Published: (2012-03-01) -
The efficiency and safety of adalimumab treatment in patients with active rheumatoid arthritis unresponsive to standard therapy: Russian national study results
by: D E Karateev, et al.
Published: (2012-08-01) -
Efficacy and tolerability of adalimumab (humira) in patients with active rheumatoid arthritis
by: I G Salikhov, et al.
Published: (2010-12-01) -
Efficacy and Safety of Adalimumab Biosimilars: Current Critical Clinical Data in Rheumatoid Arthritis
by: XiaoQin Lu, et al.
Published: (2021-04-01)